Akèy › Atak kè
Etid klinik pou Atak kè ap rekrite nan Etazini
23 etid pou Atak kè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY6 etid
- Dallas, TX6 etid
- Rochester, MN6 etid
- Boston, MA5 etid
- Detroit, MI4 etid
- Boca Raton, FL4 etid
- Nashville, TN4 etid
- Knoxville, TN4 etid
- Los Angeles, CA4 etid
- Hartford, CT4 etid
- Houston, TX4 etid
- Greensboro, NC3 etid
- Austin, TX3 etid
- Huntsville, AL3 etid
- Tucson, AZ3 etid
- Charlotte, NC3 etid
- Richmond, VA3 etid
- Baltimore, MD3 etid
- San Diego, CA3 etid
- Memphis, TN3 etid
- Waterbury, CT3 etid
- Santa Monica, CA3 etid
- Winston-Salem, NC3 etid
- Arlington, VA3 etid
- The Woodlands, TX3 etid
- Raleigh, NC3 etid
- Philadelphia, PA3 etid
- Minneapolis, MN3 etid
- Durham, NC3 etid
- Norfolk, VA3 etid
Pa eta
- Alabama3 etid
- Arizona4 etid
- Colorado3 etid
- Connecticut7 etid
- Florid5 etid
- Georgia3 etid
- Illinois3 etid
- Indiana4 etid
- Kalifòni5 etid
- Kansas3 etid
- Kentucky3 etid
- Lwizyàn3 etid
- Maryland3 etid
- Massachusetts5 etid
- Michigan6 etid
- Minnesota8 etid
- Mississippi3 etid
- Missouri3 etid
- New Jersey5 etid
- New York7 etid
- North Carolina6 etid
- Ohio5 etid
- Pennsylvania3 etid
- Tennessee5 etid
- Texas8 etid
- Utah3 etid
- Virginia4 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961Implementation of IVS3 for Upper Limb Motor Recovery
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06483230Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT05111288An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Ap rekriteFaz 3
Laj 50 a 105 · Tout sèks · Mizajou Aug 21, 2026 · NCT07136012Circulating Markers for Ischemic Heart Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT00762333Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT04321512TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT07541014AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT06699056Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT04521699Heart Attack Research Program: Platelet Sub-Study (HARP)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 21 a 99 · Fanm · Mizajou Apr 20, 2026 · NCT03022552Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Apr 9, 2026 · NCT06271577Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT04774159Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study
Ap rekriteEtid obsèvasyon
Laj 45 ak plis · Tout sèks · Mizajou Mar 19, 2026 · NCT04973397Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jan 29, 2026 · NCT06374277Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jan 27, 2026 · NCT06927739The "Virtual" Multicenter Spontaneous Coronary Artery Dissection (SCAD) Registry
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jan 23, 2026 · NCT01429727Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Jan 21, 2026 · NCT06569121Diffusion MRI in Heart Failure
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 a 85 · Tout sèks · Mizajou Dec 24, 2025 · NCT02973633Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2025 · NCT05972070Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 8, 2024 · NCT05305911Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Ap rekriteEtid obsèvasyon
Laj 20 a 90 · Tout sèks · Mizajou Aug 22, 2024 · NCT01258231Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou May 7, 2024 · NCT03588286Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.